Theriva Biologics, Inc. Balance Sheet
TOVX|1 years of annual SEC 10-K data (FY2011-FY2011)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity. All figures from audited SEC 10-K filings.
Theriva Biologics, Inc. had $4M in total assets and $4M in shareholders' equity as of FY2011.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.80 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2011 |
|---|---|
| Accounts Receivable | $339.0K |
| Current Assets | $3.5M |
| PP&E (Net) | $475.0K |
| Total Assets | $4.1M |
| Current Liabilities | $500.0K |
| Shareholders' Equity | $3.5M |